STEPUPIORS PIs featured in EACR's Cancer Researcher Magazine
STEPUPIORS PIs Milena Cavic, Jerome Zoidakis, Sergi Castellví-Bel and Remond J.A. Fijneman were featured in the Cancer Researcher Magazine of the European Association for Cancer Research. They presented project aims and first achievements, giving advice to a wide audience of over 12,000 EACR members on how to use widening funds to increase the visibility and excellence of cancer research across Europe.
New scientific publications within WP2
2. Marinkovic M, Stojanovic-Rundic S, Stanojevic A, Tomasevic A, Jankovic R, Zoidakis J, Castellví-Bel S, Fijneman RJA, Cavic M, Radulovic M. Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy Prediction. Journal of Clinical Medicine. 2024; 13(2):421. doi.org/10.3390/jcm13020421.
3. Stanojevic A, Spasic J, Marinkovic M, Stojanovic-Rundic S, Jankovic R, Djuric A, Zoidakis J, Fijneman RJA, Castellvi-Bel S and Cavic M (2024) Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy. Front. Genet. 14:1299599. doi: 10.3389/fgene.2023.1299599
https://www.frontiersin.org/
IORS Training and Strategic Visit to NKI-AVL
Annual Stakeholder Meeting
At the end of the year, we hosted a gathering for our partners and friends in a joyful and festive environment. We discussed the events and accomplishments that marked the year 2023 as well as the future plans of the STEPUPIORS team. We were delighted to hear the opinions and suggestions of exceptional professionals from various fields. We appreciate the constructive criticisms and suggestions that were given, and we will take them into account while implementing our development plan. As a result, we are even more confident in achieving joint success in the future.
Participation at the 73rd conference of the Hellenic Society of Biochemistry and Molecular Biology (HSBMB)
Dr Julie Courraud received an honorable mention for her lecture on the MS-based diagnostic typing of amyloid protein, the first clinical application of proteomics in Greece. Dr Guillaume Médard, the Award winner of the Srpsko društvo istraživača raka SDIR-6 congress, gave a short talk on expanding chemoproteomics toolbox and the advantages of MS-based proteomics in studying the biochemical effect of small molecules. Dr Ana Đurić presented the establishment of the first Rectal Cancer Biobank at the Institute for Oncology and Radiology of Serbia highlighting the importance of good biobanking practice for translational cancer research in Serbia.
HSBMB2023 included topics of modern Biochemistry and Molecular Biology. In a pleasant and inspiring atmosphere, driven by the energy of young scientists, interesting discussions followed each lecture and opened the door to new ideas and scientific collaborations. Metabolomics experiments soon to start in Athens within the project framework.
Lectures at the regional 60th Oncology Congress of the Serbian Medical Society
STEPUPIORS project participants Miljana Tanic, Radmila Jankovic, Jelena Spasic, Suzana Stojanovic-Rundic, Mladen Marinkovic, Ana Krivokuca, Fedja Djordjevic and Milena Cavic presented highly relevant results at the regional 60th Oncology Congress of the Serbian Medical Society and discussed on:
– Application of artificial intelligence in oncology
– Application of radiomics in predicting the response of locally advanced rectal cancer
– Immunotherapy
– Profiling new biomarkers in rectal cancer using omics approaches
– NGS testing of biomarkers
– MRI diagnostics for rectal cancer
– Watch & wait strategy in rectal cancer
– Malnutrition – significance for therapy decision making in oncology
Looking forward to exciting discussions next year!
STEPUPIORS participation at Cancer Patient Forum at the 60th Oncology Congress of the Serbian Medical Society
During the 60th Oncology Congress of the Serbian Medical Society STEPUPIORS participants Dr Suzana Stojanovic-Rundic, radiation oncologist, Dr Milan Kocic, oncological surgeon, Dr Mladen Marinkovic, radiation oncologist, Dr Jelena Spasic, medical oncologist and Dr Marija Djordjic Crnogorac, molecular biologist, had useful discussions with patients and patient advocates at the Forum for Cancer Patients held on November 29, 2023. The covered topics included details on surgical treatment of colorectal cancer and colostomy, as well as radiotherapy combined with chemotherapy. A special section was dedicated to the logistics of patient flow within the Genetic Counseling for Hereditary Cancers Department at the Institute for Oncology and Radiology of Serbia, covering genetic testing for the presence of Lynch Syndrome and other associated diseases.
For further information, please contact Dr Marija Djordjic Crnogorac and Dr Ana Krivokuca at geneticko.savetovanje.iors@
